<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 09 Mar 2026 05:01:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>CoverMyMeds Expands Specialty Access and Affordability Solutions to Accelerate Therapy Journeys</title>
   <link>http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;i&gt;New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.oh.colbus&quot; idsrc=&quot;xmltag.org&quot; &gt;COLUMBUS, Ohio&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 9, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; today announced the launch of expanded Specialty Access and Affordability Solutions designed to help patients start therapies faster. The new capabilities deliver an industry-first, fully integrated medication access experience that brings benefits investigation, medical and pharmacy prior authorization and patient services enrollment together directly within the &lt;span value=&quot;ACORN:4277840465&quot; idsrc=&quot;xmltag.org&quot; &gt;CoverMyMeds&lt;/span&gt; workflow.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
            </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CoverMyMeds+Expands+Specialty+Access+and+Affordability+Solutions+to+Accelerate+Therapy+Journeys/26127985.html</guid>
   <pubDate>Mon, 09 Mar 2026 05:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42778404</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08462657</category>
   	  </item>
  <item>
   <title>McKesson (MCK) call put ratio 4.1 calls to 1 put as share price down 1.6%</title>
   <link>http://www.streetinsider.com/Options/McKesson+%28MCK%29+call+put+ratio+4.1+calls+to+1+put+as+share+price+down+1.6%25/26123396.html</link>
   <description>&lt;p&gt;McKesson (NYSE: MCK) 30-day option implied volatility is at 29; compared to its 52-week range of 19 to 44. Call put ratio 4.1 calls to 1 put as share price down 1.6%.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Options/McKesson+%28MCK%29+call+put+ratio+4.1+calls+to+1+put+as+share+price+down+1.6%25/26123396.html</guid>
   <pubDate>Fri, 06 Mar 2026 10:31:44 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	  </item>
  <item>
   <title>Form  8-K        MCKESSON CORP             For: Mar 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+06/26122409.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26122409.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+06/26122409.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	  </item>
  <item>
   <title>Form  8-K        MCKESSON CORP             For: Mar 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+06/26122409.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26122409.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+06/26122409.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences</title>
   <link>http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</link>
   <description>
&lt;p&gt;    IRVING, Texas--(BUSINESS WIRE)--
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

&lt;/p&gt;&lt;p&gt;
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.

&lt;/p&gt;&lt;p&gt;
McKesson Corporation has reaffirmed fiscal 2026</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/McKesson+Corporation+Announces+Fourth+Quarter+Fiscal+2026+Earnings+Release+Date+and+Participation+in+Upcoming+Conferences/26122321.html</guid>
   <pubDate>Fri, 06 Mar 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	  </item>
  <item>
   <title>McKesson (MCK) call put ratio 1.6 calls to 1 put as share price down 5%</title>
   <link>http://www.streetinsider.com/Options/McKesson+%28MCK%29+call+put+ratio+1.6+calls+to+1+put+as+share+price+down+5%25/26117697.html</link>
   <description>&lt;p&gt;McKesson (NYSE: MCK) 30-day option implied volatility is at 28; compared to its 52-week range of 19 to 44. Call put ratio 1.6 calls to 1 put as share price down 5%.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Options/McKesson+%28MCK%29+call+put+ratio+1.6+calls+to+1+put+as+share+price+down+5%25/26117697.html</guid>
   <pubDate>Thu, 05 Mar 2026 13:04:09 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	  </item>
  <item>
   <title>BofA Securities Reiterates Buy Rating on McKesson (MCK) amid CFO retirement</title>
   <link>http://www.streetinsider.com/Analyst+Comments/BofA+Securities+Reiterates+Buy+Rating+on+McKesson+%28MCK%29+amid+CFO+retirement/26116783.html</link>
   <description>&lt;p&gt;BofA Securities analyst Michael Cherny reiterated a Buy rating and $970.00 price target on McKesson (NYSE: MCK)&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;Britt Vitalone navigated McKesson through the opioid litigation of the late 2010s and helped facilitate through capital deployment and execution one of the best total shareholder return stories of the past decade in healthcare. McKesson’s recent capital deployment strategy, including the acquisition of oncology clinics has further shaped to differentiate McKesson among a very impressive set of peers (Cencora and Cardinal Health). Looking forward, it will be important for the new CFO Kenny Cheung to get settled with MCK’s capital deployment</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/BofA+Securities+Reiterates+Buy+Rating+on+McKesson+%28MCK%29+amid+CFO+retirement/26116783.html</guid>
   <pubDate>Thu, 05 Mar 2026 10:28:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	  </item>
  <item>
   <title>Leerink Partners Reiterates Outperform Rating on McKesson (MCK) following CFO retirement announcement</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Leerink+Partners+Reiterates+Outperform+Rating+on+McKesson+%28MCK%29+following+CFO+retirement+announcement/26116452.html</link>
   <description>&lt;p&gt;Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $1,085.00 price target on McKesson (NYSE: MCK)&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;We certainly weren't expecting news of longtime CFO Britt Vitalone's retirement after what has been an extremely strong run for the company during his time in the role. We appreciate that Mr. Vitalone is staying onboard through the separation of the MedicalSurgical business in an advisory role, supporting an orderly transition as new CFO Kenny Cheung joins MCK in late May. The spin is an additional element to what is already a sizable CFO role, so the extra support is warranted,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Leerink+Partners+Reiterates+Outperform+Rating+on+McKesson+%28MCK%29+following+CFO+retirement+announcement/26116452.html</guid>
   <pubDate>Thu, 05 Mar 2026 09:31:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	  </item>
  <item>
   <title>Evercore ISI Reiterates Outperform Rating on McKesson (MCK) following CFO retirement announcement</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Evercore+ISI+Reiterates+Outperform+Rating+on+McKesson+%28MCK%29+following+CFO+retirement+announcement/26116254.html</link>
   <description>&lt;p&gt;Evercore ISI analyst Elizabeth Anderson reiterated an Outperform rating and $1,000.00 price target on McKesson (NYSE: MCK)&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;Today MCK announced that CFO Britt Vitalone will retire after 20 years with the company, including more than eight as CFO, during which he helped strengthen its financial performance and capital discipline... Succeeding him on May 29, 2026 will be Kenny Cheung, a seasoned finance executive with nearly two decades of global leadership experience... With Britt a MCK institution, today’s announcement has a bit of an end of an era feeling to it. Britt has been CFO for eight years, helping</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Evercore+ISI+Reiterates+Outperform+Rating+on+McKesson+%28MCK%29+following+CFO+retirement+announcement/26116254.html</guid>
   <pubDate>Thu, 05 Mar 2026 09:02:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	  </item>
  <item>
   <title>Form  8-K        MCKESSON CORP             For: Mar 03</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+03/26115576.html</link>
   <description>si-local-file:///var/storage/secattach/20260305/26115576.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+03/26115576.html</guid>
   <pubDate>Thu, 05 Mar 2026 08:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	  </item>
  <item>
   <title>Form  8-K        MCKESSON CORP             For: Mar 03</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+03/26115576.html</link>
   <description>si-local-file:///var/storage/secattach/20260305/26115576.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MCKESSON+CORP+++++++++++++For%3A+Mar+03/26115576.html</guid>
   <pubDate>Thu, 05 Mar 2026 08:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05049245</category>
   	  </item>
 </channel>
</rss>
